Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:04 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases

ClinicalTrials.gov · NCT04117243 · Registry updated: 2025-07-28

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2020-01-20. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
Tranexamic acid (drug) — also listed as: Kapron
Oxytocin (drug) — also listed as: syntocinone

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Faculty of Medicine
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)

ClinicalTrials.gov · NCT01908205 · Registry updated: 2025-07-16

Condition / research focus: Autism Spectrum Disorder
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2013-09. Completion: 2016-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 2 listed sites

University of Minnesota
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders

ClinicalTrials.gov · NCT01788072 · Registry updated: 2025-07-16

Condition / research focus: Autism Spectrum Disorder
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2014-06. Completion: 2017-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 2 listed sites

St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Site recruitment: Not reported
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

ClinicalTrials.gov · NCT07053930 · Registry updated: 2025-07-08

Condition / research focus: Labor
Sponsor: RESnTEC, Institute of Research
Countries with listed sites: Pakistan
Registry dates and results: Start: 2024-10-01. Completion: 2025-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intraumbilical oxytocin (drug)
Intravenous oxytocin (drug)

Where the study takes place — 1 listed sites

Sadiq Abbasi Hospital
Bahawalpur, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Expectation Effects on Emotional Processing

ClinicalTrials.gov · NCT07031804 · Registry updated: 2025-06-27

Condition / research focus: Expectation Effects on Emotional Processing
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Countries with listed sites: Germany
Registry dates and results: Start: 2025-06. Completion: 2026-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Saline Nasal Spray (other)
Saline Nasal Spray (other)

Where the study takes place — 1 listed sites

University Medical Center Hamburg-Eppendorf, Institute of Systems Neuroscience
Hamburg, Free and Hanseatic City of Hamburg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Hair Biomarkers Study

ClinicalTrials.gov · NCT07011082 · Registry updated: 2025-06-24

Condition / research focus: Healthy
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-18. Completion: 2029-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Stress preventative measures (other)

Where the study takes place — 1 listed sites

Stanford University
Palo Alto, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Oxytocin and Fetal Heart Rate Changes

ClinicalTrials.gov · NCT03232918 · Registry updated: 2025-06-04

Condition / research focus: Fetal Bradycardia Complicating Labor and Delivery; Fetal Bradycardia During Labor; Fetal Heart Rate or Rhythm Abnormality Affecting Fetus
Sponsor: Unyime Ituk
Countries with listed sites: United States
Registry dates and results: Start: 2019-02-20. Completion: 2025-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Half dose Oxytocin (drug)

Where the study takes place — 2 listed sites

University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Oxytocin Receptor Expression in Pregnancy

ClinicalTrials.gov · NCT03907735 · Registry updated: 2025-05-31

Condition / research focus: Post-Abortion; Hemorrhage, Obstetric
Sponsor: Oregon Health and Science University
Countries with listed sites: United States
Registry dates and results: Start: 2019-06-03. Completion: 2025-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Myometrial tissue sample collection (other)

Where the study takes place — 1 listed sites

Oregon Health & Science University
Portland, Oregon, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor

ClinicalTrials.gov · NCT06990217 · Registry updated: 2025-05-25

Condition / research focus: Induction of Labor; Augmentation of Labor
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2025-06. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin Grindeks 10 IU/ml- solution for injection (drug)

Where the study takes place — 1 listed sites

Haemek Medical Center
Afula, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin, Stress, Craving, Opioid Use Disorder

ClinicalTrials.gov · NCT04051619 · Registry updated: 2025-05-25

Condition / research focus: Opioid Use Disorder
Sponsor: Brown University
Countries with listed sites: United States
Registry dates and results: Start: 2020-01-06. Completion: 2023-12-23 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin, 40 IU, twice a day for 7 days (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Brown University
Providence, Rhode Island, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

ClinicalTrials.gov · NCT06676774 · Registry updated: 2025-05-23

Condition / research focus: Arginine Vasopressin Deficiency; Diabetes Insipidus
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-05-16. Completion: 2027-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (other)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder

ClinicalTrials.gov · NCT05357521 · Registry updated: 2025-05-16

Condition / research focus: Borderline Personality Disorder; Oxytocin
Sponsor: University of Geneva, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2022-03-01. Completion: 2025-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

stress test (other)

Where the study takes place — 1 listed sites

Young Adult Psychiatric Unit
Geneva, Canton of Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy

ClinicalTrials.gov · NCT06557239 · Registry updated: 2025-05-16

Condition / research focus: Depression, Anxiety
Sponsor: Tatiana Aboulafia Brakha
Countries with listed sites: Switzerland
Registry dates and results: Start: 2024-08-05. Completion: 2024-12-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lysergic Acid Diethylamide (LSD) (drug)

Where the study takes place — 1 listed sites

Geneva University Hospitals
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Experimental Study on Alcohol Use and Behavior in Young Adults

ClinicalTrials.gov · NCT06199076 · Registry updated: 2025-05-07

Condition / research focus: Alcohol Use Disorder
Sponsor: Karolinska Institutet
Countries with listed sites: Sweden
Registry dates and results: Start: 2023-10-17. Completion: 2025-04-23 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Syntocinon Intranasal Spray

Where the study takes place — 1 listed sites

Karolinska Institutet, Division of Psychology
Solna, Stockholm County, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin

ClinicalTrials.gov · NCT06960850 · Registry updated: 2025-05-07

Condition / research focus: Propranolol; Labour Induction
Sponsor: Federal Teaching Hospital Abakaliki
Countries with listed sites: Nigeria
Registry dates and results: Start: 2025-06-01. Completion: 2025-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propranolol (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix

ClinicalTrials.gov · NCT04000438 · Registry updated: 2025-05-06

Condition / research focus: Labor Onset and Length Abnormalities
Sponsor: Dilafor AB
Countries with listed sites: Finland · Sweden
Registry dates and results: Start: 2019-06-21. Completion: 2023-03-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DF01 (drug) — also listed as: tafoxiparin
PL1 (drug) — also listed as: Placebo

Where the study takes place — 7 listed sites

Naistenklinikka (HUS)
Helsinki, Finland
Site recruitment: Not reported
Tampere University Hospital
Tampere, Finland
Site recruitment: Not reported
Kvinnokliniken Universitetssjukhuset Linköping
Linköping, Sweden
Site recruitment: Not reported
Lund University Hospital
Lund, Sweden
Site recruitment: Not reported
Kvinnokliniken Skaraborgs Sjukhus
Skövde, Sweden
Site recruitment: Not reported
Kvinnokliniken Södersjukhuset
Stockholm, Sweden
Site recruitment: Not reported
Förlossningsavdelningen Akademiska Universitetssjukhuset
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

ClinicalTrials.gov · NCT05245227 · Registry updated: 2025-05-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: Stony Brook University
Countries with listed sites: United States
Registry dates and results: Start: 2025-01-27. Completion: 2027-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sublingual Misoprostol (drug)
IV Oxytocin (drug)

Where the study takes place — 1 listed sites

Stony Brook University
Stony Brook, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.

ClinicalTrials.gov · NCT06956365 · Registry updated: 2025-05-04

Condition / research focus: Cesarean Section
Sponsor: Yuzuncu Yil University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-05-14. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Group-C (procedure) — also listed as: Group Carbetosin
Group-O (procedure) — also listed as: Group Oxytocine

Where the study takes place — 1 listed sites

Van Yuzuncu Yil University
Van, Tuşba, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors

ClinicalTrials.gov · NCT06955650 · Registry updated: 2025-05-02

Condition / research focus: Pain, Face
Sponsor: Aarhus University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2021-04-30. Completion: 2022-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor (drug)

Where the study takes place — 1 listed sites

Aarhus University Hospital
Aarhus, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

ClinicalTrials.gov · NCT04341662 · Registry updated: 2025-04-18

Condition / research focus: Post-Partum Haemorrhage
Sponsor: University of Birmingham
Countries with listed sites: Kenya · Nigeria · Pakistan · South Africa · Tanzania
Registry dates and results: Start: 2020-10-13. Completion: 2023-03-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

E-MOTIVE intervention (behavioral)
Usual care (behavioral)

Where the study takes place — 6 listed sites

University of Nairobi
Nairobi, Kenya
Site recruitment: Not reported
Bayero University
Kano, Nigeria
Site recruitment: Not reported
Aga Khan University
Karachi, Pakistan
Site recruitment: Not reported
University of Cape Town
Cape Town, South Africa
Site recruitment: Not reported
University of the Witwatersrand
Johannesburg, South Africa
Site recruitment: Not reported
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 19:04 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 2CompletedINTERVENTIONAL

Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases

ClinicalTrials.gov · NCT04117243 · Registry updated: 2025-07-28

Condition / research focus: Post Partum Hemorrhage
Sponsor: Cairo University
Countries with listed sites: Egypt
Registry dates and results: Start: 2020-01-20. Completion: 2020-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Misoprostol (drug) — also listed as: Cytotec
Tranexamic acid (drug) — also listed as: Kapron
Oxytocin (drug) — also listed as: syntocinone

Where the study takes place — 1 listed sites

Faculty of Medicine
Cairo, Egypt
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)

ClinicalTrials.gov · NCT01908205 · Registry updated: 2025-07-16

Condition / research focus: Autism Spectrum Disorder
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Countries with listed sites: Canada · United States
Registry dates and results: Start: 2013-09. Completion: 2016-03 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 2 listed sites

University of Minnesota
Minneapolis, Minnesota, United States
Site recruitment: Not reported
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

INtranasal OXyTocin for the Treatment of Autism Spectrum Disorders

ClinicalTrials.gov · NCT01788072 · Registry updated: 2025-07-16

Condition / research focus: Autism Spectrum Disorder
Sponsor: Holland Bloorview Kids Rehabilitation Hospital
Countries with listed sites: Canada
Registry dates and results: Start: 2014-06. Completion: 2017-10 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intranasal Oxytocin (drug) — also listed as: Syntocinon
Placebo (drug)

Where the study takes place — 2 listed sites

St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
Site recruitment: Not reported
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

ClinicalTrials.gov · NCT07053930 · Registry updated: 2025-07-08

Condition / research focus: Labor
Sponsor: RESnTEC, Institute of Research
Countries with listed sites: Pakistan
Registry dates and results: Start: 2024-10-01. Completion: 2025-03-31 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Intraumbilical oxytocin (drug)
Intravenous oxytocin (drug)

Where the study takes place — 1 listed sites

Sadiq Abbasi Hospital
Bahawalpur, Punjab Province, Pakistan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Expectation Effects on Emotional Processing

ClinicalTrials.gov · NCT07031804 · Registry updated: 2025-06-27

Condition / research focus: Expectation Effects on Emotional Processing
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Countries with listed sites: Germany
Registry dates and results: Start: 2025-06. Completion: 2026-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Saline Nasal Spray (other)
Saline Nasal Spray (other)

Where the study takes place — 1 listed sites

University Medical Center Hamburg-Eppendorf, Institute of Systems Neuroscience
Hamburg, Free and Hanseatic City of Hamburg, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Hair Biomarkers Study

ClinicalTrials.gov · NCT07011082 · Registry updated: 2025-06-24

Condition / research focus: Healthy
Sponsor: Stanford University
Countries with listed sites: United States
Registry dates and results: Start: 2024-11-18. Completion: 2029-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Stress preventative measures (other)

Where the study takes place — 1 listed sites

Stanford University
Palo Alto, California, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Oxytocin and Fetal Heart Rate Changes

ClinicalTrials.gov · NCT03232918 · Registry updated: 2025-06-04

Condition / research focus: Fetal Bradycardia Complicating Labor and Delivery; Fetal Bradycardia During Labor; Fetal Heart Rate or Rhythm Abnormality Affecting Fetus
Sponsor: Unyime Ituk
Countries with listed sites: United States
Registry dates and results: Start: 2019-02-20. Completion: 2025-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Half dose Oxytocin (drug)

Where the study takes place — 2 listed sites

University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site recruitment: Not yet recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableActive, not recruitingOBSERVATIONAL

Oxytocin Receptor Expression in Pregnancy

ClinicalTrials.gov · NCT03907735 · Registry updated: 2025-05-31

Condition / research focus: Post-Abortion; Hemorrhage, Obstetric
Sponsor: Oregon Health and Science University
Countries with listed sites: United States
Registry dates and results: Start: 2019-06-03. Completion: 2025-08 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Myometrial tissue sample collection (other)

Where the study takes place — 1 listed sites

Oregon Health & Science University
Portland, Oregon, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Comparing High Versus Low Dose of Oxytocin, in Gravida Women With BMI 30 and Above Which Are Undergoing Induction of Labor

ClinicalTrials.gov · NCT06990217 · Registry updated: 2025-05-25

Condition / research focus: Induction of Labor; Augmentation of Labor
Sponsor: HaEmek Medical Center, Israel
Countries with listed sites: Israel
Registry dates and results: Start: 2025-06. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin Grindeks 10 IU/ml- solution for injection (drug)

Where the study takes place — 1 listed sites

Haemek Medical Center
Afula, Israel
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Oxytocin, Stress, Craving, Opioid Use Disorder

ClinicalTrials.gov · NCT04051619 · Registry updated: 2025-05-25

Condition / research focus: Opioid Use Disorder
Sponsor: Brown University
Countries with listed sites: United States
Registry dates and results: Start: 2020-01-06. Completion: 2023-12-23 (may be estimated). Results are posted in this registry.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

intranasal oxytocin, 40 IU, twice a day for 7 days (drug) — also listed as: Pitocin

Where the study takes place — 1 listed sites

Brown University
Providence, Rhode Island, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2RecruitingINTERVENTIONAL

Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls

ClinicalTrials.gov · NCT06676774 · Registry updated: 2025-05-23

Condition / research focus: Arginine Vasopressin Deficiency; Diabetes Insipidus
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2025-05-16. Completion: 2027-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug)
Placebo (other)

Where the study takes place — 1 listed sites

University Hospital Basel
Basel, Switzerland
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Interplay Between Oxytocin and Cortisol During Stress in Borderline Personality Disorder

ClinicalTrials.gov · NCT05357521 · Registry updated: 2025-05-16

Condition / research focus: Borderline Personality Disorder; Oxytocin
Sponsor: University of Geneva, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2022-03-01. Completion: 2025-04-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

stress test (other)

Where the study takes place — 1 listed sites

Young Adult Psychiatric Unit
Geneva, Canton of Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Salivary Oxytocin as a Biomarker in Psychedelic Assisted Psychotherapy

ClinicalTrials.gov · NCT06557239 · Registry updated: 2025-05-16

Condition / research focus: Depression, Anxiety
Sponsor: Tatiana Aboulafia Brakha
Countries with listed sites: Switzerland
Registry dates and results: Start: 2024-08-05. Completion: 2024-12-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Lysergic Acid Diethylamide (LSD) (drug)

Where the study takes place — 1 listed sites

Geneva University Hospitals
Geneva, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2TerminatedINTERVENTIONAL

Experimental Study on Alcohol Use and Behavior in Young Adults

ClinicalTrials.gov · NCT06199076 · Registry updated: 2025-05-07

Condition / research focus: Alcohol Use Disorder
Sponsor: Karolinska Institutet
Countries with listed sites: Sweden
Registry dates and results: Start: 2023-10-17. Completion: 2025-04-23 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Oxytocin nasal spray (drug) — also listed as: Syntocinon Intranasal Spray

Where the study takes place — 1 listed sites

Karolinska Institutet, Division of Psychology
Solna, Stockholm County, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

Effects of Oral Propranolol on Induction-Delivery Interval During Induction of Labour With Oxytocin

ClinicalTrials.gov · NCT06960850 · Registry updated: 2025-05-07

Condition / research focus: Propranolol; Labour Induction
Sponsor: Federal Teaching Hospital Abakaliki
Countries with listed sites: Nigeria
Registry dates and results: Start: 2025-06-01. Completion: 2025-12-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Propranolol (drug)
Placebo (other)

Where the study takes place — 1 listed sites

Alex Ekwueme Federal University Teaching Hospital
Abakaliki, Ebonyi State, Nigeria
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix

ClinicalTrials.gov · NCT04000438 · Registry updated: 2025-05-06

Condition / research focus: Labor Onset and Length Abnormalities
Sponsor: Dilafor AB
Countries with listed sites: Finland · Sweden
Registry dates and results: Start: 2019-06-21. Completion: 2023-03-30 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

DF01 (drug) — also listed as: tafoxiparin
PL1 (drug) — also listed as: Placebo

Where the study takes place — 7 listed sites

Naistenklinikka (HUS)
Helsinki, Finland
Site recruitment: Not reported
Tampere University Hospital
Tampere, Finland
Site recruitment: Not reported
Kvinnokliniken Universitetssjukhuset Linköping
Linköping, Sweden
Site recruitment: Not reported
Lund University Hospital
Lund, Sweden
Site recruitment: Not reported
Kvinnokliniken Skaraborgs Sjukhus
Skövde, Sweden
Site recruitment: Not reported
Kvinnokliniken Södersjukhuset
Stockholm, Sweden
Site recruitment: Not reported
Förlossningsavdelningen Akademiska Universitetssjukhuset
Uppsala, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3RecruitingINTERVENTIONAL

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

ClinicalTrials.gov · NCT05245227 · Registry updated: 2025-05-04

Condition / research focus: Postpartum Hemorrhage
Sponsor: Stony Brook University
Countries with listed sites: United States
Registry dates and results: Start: 2025-01-27. Completion: 2027-01-01 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sublingual Misoprostol (drug)
IV Oxytocin (drug)

Where the study takes place — 1 listed sites

Stony Brook University
Stony Brook, New York, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.

ClinicalTrials.gov · NCT06956365 · Registry updated: 2025-05-04

Condition / research focus: Cesarean Section
Sponsor: Yuzuncu Yil University
Countries with listed sites: Turkey (Türkiye)
Registry dates and results: Start: 2024-05-14. Completion: 2025-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Group-C (procedure) — also listed as: Group Carbetosin
Group-O (procedure) — also listed as: Group Oxytocine

Where the study takes place — 1 listed sites

Van Yuzuncu Yil University
Van, Tuşba, Turkey (Türkiye)
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Early Phase 1CompletedINTERVENTIONAL

First-in-man Imaging of a New PET Radiotracer for Oxytocin Receptors

ClinicalTrials.gov · NCT06955650 · Registry updated: 2025-05-02

Condition / research focus: Pain, Face
Sponsor: Aarhus University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2021-04-30. Completion: 2022-06-30 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Imaging procedure to measure the distribution of a newly developed radiolabeled ligand for the oxytocin receptor (drug)

Where the study takes place — 1 listed sites

Aarhus University Hospital
Aarhus, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

A Clinical Trial to Study the Effectiveness of a Care Bundle to Prevent Bleeding After a Woman Has Given Birth

ClinicalTrials.gov · NCT04341662 · Registry updated: 2025-04-18

Condition / research focus: Post-Partum Haemorrhage
Sponsor: University of Birmingham
Countries with listed sites: Kenya · Nigeria · Pakistan · South Africa · Tanzania
Registry dates and results: Start: 2020-10-13. Completion: 2023-03-24 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

E-MOTIVE intervention (behavioral)
Usual care (behavioral)

Where the study takes place — 6 listed sites

University of Nairobi
Nairobi, Kenya
Site recruitment: Not reported
Bayero University
Kano, Nigeria
Site recruitment: Not reported
Aga Khan University
Karachi, Pakistan
Site recruitment: Not reported
University of Cape Town
Cape Town, South Africa
Site recruitment: Not reported
University of the Witwatersrand
Johannesburg, South Africa
Site recruitment: Not reported
Muhimbili University of Health and Allied Sciences
Dar es Salaam, Tanzania
Site recruitment: Not reported

Original record, eligibility, contacts and results →